Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Epidemiological Aspects (Prevalence and Risk of Heart Failure Related to Blood Pressure)

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F18%3AN0000103" target="_blank" >RIV/00064190:_____/18:N0000103 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://doi.org/10.1007/978-3-319-93320-7_1" target="_blank" >https://doi.org/10.1007/978-3-319-93320-7_1</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/978-3-319-93320-7_1" target="_blank" >10.1007/978-3-319-93320-7_1</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Epidemiological Aspects (Prevalence and Risk of Heart Failure Related to Blood Pressure)

  • Popis výsledku v původním jazyce

    According to the European Society of Cardiology guidelines, HF is defined as a clinical syndrome characterized by typical symptoms (e.g., breathlessness, ankle swelling, and fatigue) that may be accompanied by signs (e.g., elevated jugular venous pressure, pulmonary crackles, and peripheral edema) caused by a structural and/or functional cardiac abnormality resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress [1]. Heart failure can present with preserved ejection fraction (HFpEF), midrange ejection fraction (HFmrEF), or reduced ejection fraction (HFrEF). These three entities differ in their epidemiological profiles, presentation, and mechanisms. Compared with HFrEF, patients with HFpEF are older and more commonly have hypertension and atrial fibrillation, while a history of myocardial infarction is less common. In several studies, HFpEF was more common in females than in males. This may be partially explained by sex distribution in the highest age groups (60% of the US population aged ≥75 years are women). A recent analysis has shown that among individuals of similar age and similar prevalence of other HF risk factors, women are not at higher risk of HFpEF than men but are at a lower risk for HFrEF. Heart failure with midrange ejection fraction is an intermediate phenotype, with the prevalence of ischemic heart disease (IHD) similar to that of HFrEF, while other demographic characteristics, symptom profile, comorbidities, laboratory values, and short-term outcomes are closer to those with HFpEF.

  • Název v anglickém jazyce

    Epidemiological Aspects (Prevalence and Risk of Heart Failure Related to Blood Pressure)

  • Popis výsledku anglicky

    According to the European Society of Cardiology guidelines, HF is defined as a clinical syndrome characterized by typical symptoms (e.g., breathlessness, ankle swelling, and fatigue) that may be accompanied by signs (e.g., elevated jugular venous pressure, pulmonary crackles, and peripheral edema) caused by a structural and/or functional cardiac abnormality resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress [1]. Heart failure can present with preserved ejection fraction (HFpEF), midrange ejection fraction (HFmrEF), or reduced ejection fraction (HFrEF). These three entities differ in their epidemiological profiles, presentation, and mechanisms. Compared with HFrEF, patients with HFpEF are older and more commonly have hypertension and atrial fibrillation, while a history of myocardial infarction is less common. In several studies, HFpEF was more common in females than in males. This may be partially explained by sex distribution in the highest age groups (60% of the US population aged ≥75 years are women). A recent analysis has shown that among individuals of similar age and similar prevalence of other HF risk factors, women are not at higher risk of HFpEF than men but are at a lower risk for HFrEF. Heart failure with midrange ejection fraction is an intermediate phenotype, with the prevalence of ischemic heart disease (IHD) similar to that of HFrEF, while other demographic characteristics, symptom profile, comorbidities, laboratory values, and short-term outcomes are closer to those with HFpEF.

Klasifikace

  • Druh

    C - Kapitola v odborné knize

  • CEP obor

  • OECD FORD obor

    30201 - Cardiac and Cardiovascular systems

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/NV15-27109A" target="_blank" >NV15-27109A: Dlouhodobé trendy hlavních kardiovaskulárních rizikových faktorů a jejich prediktivní hodnota v náhodně vybraném populačním vzorku, Czech post-MONICA</a><br>

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Ostatní

  • Rok uplatnění

    2018

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název knihy nebo sborníku

    Hypertension and heart failure

  • ISBN

    978-3-319-93319-1

  • Počet stran výsledku

    9

  • Strana od-do

    3-11

  • Počet stran knihy

    416

  • Název nakladatele

    Springer Nature

  • Místo vydání

    Itálie

  • Kód UT WoS kapitoly